Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1367.75
-6.80 (-0.49%)
< Home < Back

Dr Reddy's establishes formulation development lab in Hyderabad

Date: 11-03-2015

Dr Reddy's Laboratories has established a new formulation development laboratory at its facility in Miyapur in Hyderabad. This was part of expansion of its existing custom service facilities.

Following this expansion, the laboratories will form a centre of excellence for fully integrated active pharmaceutical ingredients (APIs) and formulation development services, including pre-formulation studies, prototype formulation development, process development and optimisation.

Dr Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.